Skip to main content

Table 2 Clinicopathological features of the patients and correlation of SALL4 gene expression with them

From: Role of SALL4 in the progression and metastasis of colorectal cancer

Factor Number (%) SALL4 P value
↓ / -
Tumor invasion     
T1, T2 8 (17.4%) 8 0 0.538
T3, T4 38 (82.6%) 32 6
Lymph node metastasis     
N0 33 (71.7%) 28 5 0.047*
N1 9 (19.6%) 9 0
N2 4 (8.7) 3 1
Stage     
I/II 34 (73.9%) 29 5 0.397
III/IV 12 (26.1%) 11 1
Grade     
WD 29 (63%) 25 4 0.020*
MD 16 (34.8%) 15 1
PD 1 (2.2%) 0 1
Tumor location     
Proximal 13 (28.3%) 11 2 0.611
Distal 33 (71.7%) 29 4
Sex     
Male 26 (56.5%) 22 4 0.030*
Female 20 (43.5%) 18 2
  1. WD: Well differentiated; MD: Moderately differentiated; PD: Poorly differentiated.
  2. *Significant correlation between SALL4 mRNA expression and clinicopathological feature.